Personalizing initial calcineurin inhibitor dosing by adjusting to donor CYP3A‐status in liver transplant patients

Por Monostory, Katalin, Tóth, Katalin, Kiss, Ádám, Háfra, Edit, Csikány, Nóra, Paulik, József, Sárváry, Enikő, Kóbori, László
Publicado no Br J Clin Pharmacol (2015)

Optimization of Clonazepam Therapy Adjusted to Patient’s CYP3A Status and NAT2 Genotype

Por Tóth, Katalin, Csukly, Gábor, Sirok, Dávid, Belic, Ales, Kiss, Ádám, Háfra, Edit, Déri, Máté, Menus, Ádám, Bitter, István, Monostory, Katalin
Publicado no Int J Neuropsychopharmacol (2016)

Potential Role of Patients’ CYP3A-Status in Clozapine Pharmacokinetics

Por Tóth, Katalin, Csukly, Gábor, Sirok, Dávid, Belic, Ales, Kiss, Ádám, Háfra, Edit, Déri, Máté, Menus, Ádám, Bitter, István, Monostory, Katalin
Publicado no Int J Neuropsychopharmacol (2017)